RS53021B - Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi - Google Patents

Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi

Info

Publication number
RS53021B
RS53021B YU101304A YUP101304A RS53021B RS 53021 B RS53021 B RS 53021B YU 101304 A YU101304 A YU 101304A YU P101304 A YUP101304 A YU P101304A RS 53021 B RS53021 B RS 53021B
Authority
RS
Serbia
Prior art keywords
group
heteroaryl
optionally substituted
phenyl
compound according
Prior art date
Application number
YU101304A
Other languages
English (en)
Serbian (sr)
Inventor
Nicholas A. Meanwell
Tao Wang
Kap-Sun Yeung
Zhongxing Zhang
John F. Kadow
Zhiwei Yin
Zhilei Qiu
Daniel H. Deon
Clint A. James
Edward H. Ruediger
Carol Bachand
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32312411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS53021(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of RS101304A publication Critical patent/RS101304A/sr
Publication of RS53021B publication Critical patent/RS53021B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YU101304A 2002-05-28 2003-04-30 Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi RS53021B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38350902P 2002-05-28 2002-05-28
PCT/US2003/013324 WO2004043337A2 (en) 2002-05-28 2003-04-30 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

Publications (2)

Publication Number Publication Date
RS101304A RS101304A (sr) 2006-10-27
RS53021B true RS53021B (sr) 2014-04-30

Family

ID=32312411

Family Applications (1)

Application Number Title Priority Date Filing Date
YU101304A RS53021B (sr) 2002-05-28 2003-04-30 Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi

Country Status (31)

Country Link
US (1) US20040063744A1 (OSRAM)
EP (1) EP1513832B1 (OSRAM)
JP (1) JP4446889B2 (OSRAM)
KR (1) KR101001811B1 (OSRAM)
CN (1) CN100528866C (OSRAM)
AR (1) AR040230A1 (OSRAM)
AU (1) AU2003301958B2 (OSRAM)
BR (2) BRPI0311541B1 (OSRAM)
CA (1) CA2487542C (OSRAM)
CL (1) CL2003001087A1 (OSRAM)
CO (1) CO5631440A2 (OSRAM)
DK (1) DK1513832T3 (OSRAM)
ES (1) ES2460728T3 (OSRAM)
GE (1) GEP20074152B (OSRAM)
HR (1) HRP20041137B1 (OSRAM)
IL (1) IL165200A (OSRAM)
IS (1) IS2945B (OSRAM)
MX (1) MXPA04011670A (OSRAM)
MY (1) MY139058A (OSRAM)
NO (1) NO329691B1 (OSRAM)
NZ (1) NZ536661A (OSRAM)
PE (1) PE20040526A1 (OSRAM)
PL (1) PL216388B1 (OSRAM)
PT (1) PT1513832E (OSRAM)
RS (1) RS53021B (OSRAM)
RU (1) RU2323934C2 (OSRAM)
SI (1) SI1513832T1 (OSRAM)
TW (1) TWI310381B (OSRAM)
UA (1) UA79470C2 (OSRAM)
WO (1) WO2004043337A2 (OSRAM)
ZA (1) ZA200409504B (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20050075364A1 (en) * 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
US7087610B2 (en) * 2004-06-03 2006-08-08 Bristol-Myers Squibb Company Benzothiazole antiviral agents
ATE412651T1 (de) 2004-06-09 2008-11-15 Glaxo Group Ltd Pyrrolopyridinderivate
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
AR055601A1 (es) * 2005-08-09 2007-08-29 Glaxo Group Ltd Compuestos derivados de imidazopiridina como ligandos de receptores canabinoides
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) * 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
US7504399B2 (en) * 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
AU2008257559B2 (en) * 2007-05-25 2013-10-10 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (MGLU2 receptor)
WO2009011912A1 (en) * 2007-07-18 2009-01-22 Bristol-Myers Squibb Company A composition for treating hiv comprising virus-like particles
WO2009158394A1 (en) * 2008-06-25 2009-12-30 Bristol-Myers Squibb Company Diketo azolopiperidines and azolopiperazines as anti-hiv agents
JP5433691B2 (ja) * 2008-06-25 2014-03-05 ブリストル−マイヤーズ スクイブ カンパニー Ｈｉｖ結合阻害剤としてのジケトピペリジン誘導体
US20100056540A1 (en) * 2008-09-04 2010-03-04 Bristol-Myers Squibb Company Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
KR20110136819A (ko) * 2009-02-27 2011-12-21 시가 테크놀로지스, 인크. 뎅기 바이러스 감염의 치료 및 예방을 위한 티에노피리딘 유도체
EP2414332B1 (en) 2009-04-02 2013-10-23 Shionogi&Co., Ltd. Acrylamide compounds and the use thereof
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
US8450361B2 (en) * 2010-08-06 2013-05-28 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
EP2646439B1 (en) 2010-12-02 2016-05-25 Bristol-Myers Squibb Company Alkyl amides as hiv attachment inhibitors
US8685982B2 (en) 2011-04-12 2014-04-01 Bristol-Myers Squibb Company Thioamide, amidoxime and amidrazone derivatives as HIV attachment inhibitors
US8664213B2 (en) 2011-08-29 2014-03-04 Bristol-Myers Squibb Company Spiro bicyclic diamine derivatives as HIV attachment inhibitors
WO2013033061A1 (en) 2011-08-29 2013-03-07 Bristol-Myers Squibb Company Fused bicyclic diamine derivatives as hiv attachment inhibitors
EA024872B1 (ru) * 2012-02-08 2016-10-31 Бристол-Майерс Сквибб Компани Способы получения пиперазинового пролекарства - ингибитора присоединения вич
WO2013138436A1 (en) 2012-03-14 2013-09-19 Bristol-Myers Squibb Company Cyclolic hydrazine derivatives as hiv attachment inhibitors
WO2014025854A1 (en) * 2012-08-09 2014-02-13 Bristol-Myers Squibb Company Piperidine amide derivatives as hiv attachment inhibitors
WO2014025852A1 (en) * 2012-08-09 2014-02-13 Bristol-Myers Squibb Company Tricyclic alkene derivatives as hiv attachment inhibitors
WO2017112576A1 (en) * 2015-12-21 2017-06-29 Dow Global Technologies Llc Methods for external base-free suzuki couplings
CN108059611A (zh) * 2018-01-22 2018-05-22 济南舜景医药科技有限公司 一种用于治疗心率不齐药物中间体的合成方法
CN109053575A (zh) * 2018-08-24 2018-12-21 遵义医学院 3-环丙基-1-甲基-1h-吡唑-4-甲醛的制备工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023265A (en) * 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
US5124327A (en) * 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5424329A (en) * 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
JP2002515891A (ja) * 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物
US6469006B1 (en) * 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
US20020061892A1 (en) * 2000-02-22 2002-05-23 Tao Wang Antiviral azaindole derivatives
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US6573262B2 (en) * 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives

Also Published As

Publication number Publication date
BRPI0311541B1 (pt) 2018-04-24
KR20050013558A (ko) 2005-02-04
ZA200409504B (en) 2006-05-31
CL2003001087A1 (es) 2005-02-11
IL165200A0 (en) 2005-12-18
JP2006507326A (ja) 2006-03-02
TW200406397A (en) 2004-05-01
EP1513832A4 (en) 2010-03-10
IL165200A (en) 2011-01-31
RU2323934C2 (ru) 2008-05-10
MXPA04011670A (es) 2005-03-07
AR040230A1 (es) 2005-03-23
PE20040526A1 (es) 2004-08-28
RS101304A (sr) 2006-10-27
NZ536661A (en) 2007-12-21
CO5631440A2 (es) 2006-04-28
AU2003301958B2 (en) 2009-10-01
GEP20074152B (en) 2007-07-10
US20040063744A1 (en) 2004-04-01
KR101001811B1 (ko) 2010-12-15
PL373603A1 (en) 2005-09-05
EP1513832A2 (en) 2005-03-16
HRP20041137A2 (en) 2005-06-30
DK1513832T3 (da) 2014-05-26
ES2460728T3 (es) 2014-05-14
WO2004043337A2 (en) 2004-05-27
CA2487542C (en) 2011-09-27
NO20045064L (no) 2005-02-23
AU2003301958A1 (en) 2004-06-03
SI1513832T1 (sl) 2014-04-30
NO329691B1 (no) 2010-11-29
RU2004138565A (ru) 2005-07-20
CN100528866C (zh) 2009-08-19
EP1513832B1 (en) 2014-03-05
WO2004043337A3 (en) 2004-11-11
UA79470C2 (en) 2007-06-25
IS7546A (is) 2004-11-22
CN1671697A (zh) 2005-09-21
MY139058A (en) 2009-08-28
CA2487542A1 (en) 2004-05-27
PL216388B1 (pl) 2014-03-31
PT1513832E (pt) 2014-05-22
TWI310381B (en) 2009-06-01
HRP20041137B1 (hr) 2014-11-21
JP4446889B2 (ja) 2010-04-07
IS2945B (is) 2016-05-15
BR0311541A (pt) 2006-06-06

Similar Documents

Publication Publication Date Title
RS53021B (sr) Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi
US7915283B2 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
US8039486B2 (en) Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US7902204B2 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
HRP20030694A2 (en) Composition and antiviral activity of substitutedazaindoleoxoacetic piperazine derivatives
MXPA05001441A (es) Composicion y actvidad antiviral de derivados de piperazina, azaindoloxoacetico substituidos.
ES2368430T3 (es) Indol, azaindol y derivados de piperazina n-sustituida heterocíclica relacionados.
HK1072055A (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
HK1072055B (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides